Felix Gonzalez Lopez de Turiso

Felix has been a team leader in the medicinal chemistry department at Biogen for the past 6 years where his group is involved in the discovery of new therapies for the treatment of neurological disease. Prior to his role at Biogen, Felix worked for 10 years at Amgen where he held positions of increased responsibility and was ultimately promoted to the role of principal scientist and chemistry team leader. During his research career, Felix has led and worked in teams that have delivered multiple clinical candidates within four different therapeutic areas and he is a co-author in 21 publications, and a co-inventor in 23 patent applications. Felix did his postdoctoral studies with Dennis Curran working in the development of novel radical chemistry methodology and he holds a Ph.D. in chemistry from the University of Nottingham (UK) where he synthesized the furanocembrane bis-deoxylophotoxin in the group of Gerry Pattenden.